$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled local delivery of chemotherapeutic agents for treating solid tumors 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/14
  • A61K-009/50
출원번호 US-0363519 (1999-07-29)
발명자 / 주소
  • Brem Henny
  • Langer Robert S.
  • Domb Abraham J.,ILX
출원인 / 주소
  • The Johns Hopkins University
대리인 / 주소
    Holland & Knight LLP
인용정보 피인용 횟수 : 22  인용 특허 : 74

초록

A method and devices for localized delivery of a chemotherapeutic agent to solid tumors, wherein the agent does not cross the blood-brain barrier and is characterized by poor bioavailability and/or short half-lives in vivo, are described. The devices consist of reservoirs which release drug over an

대표청구항

[ We claim:] [1.]1. A chemotherapeutic composition comprisinga biocompatible synthetic polymeric matrix incorporatingan effective amount to inhibit tumor growth when released in vivo at the site of the tumor of a water insoluble, relatively lipid insoluble chemotherapeutic agent,wherein the chemothe

이 특허에 인용된 특허 (74)

  1. Roth Gregory (Cheshire CT), 6,7-epoxy paclitaxels.
  2. Chen Shu-Hui (Hamden CT) Farina Vittorio (West Hartford CT) Roth Gregory (Cheshire CT) Kadow John (Wallingford CT), 6,7-modified paclitaxels.
  3. Wasserman David (Springfield NJ) Versfelt Charles C. (Somerville NJ) Hahn Dowon (Flemington NJ) Wachter Michael P. (Bloomsbury NJ), Absorbable polymer-drug compounds and method for making same.
  4. Lance Wolfgang (Obernburg DEX), Active agent containing solid structures for prolonged release of active agents.
  5. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  6. Domb Abraham J. (Baltimore MD), Aromatic polyanhydride compositions.
  7. Daniels Alma U. (Salt Lake City UT) Heller Jorge (Woodside CA), Biodegradable composites for internal medical use.
  8. Tuan Rocky S. (Chester Springs PA) Lin Sheldon S. (Philadelphia PA), Biodegradable drug delivery system for the prevention and treatment of osteomyelitis.
  9. Feijen Jan (Oude Grensweg NLX), Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents.
  10. Urist Marshall R. (Pacific Palisades CA), Biodegradable organic polymer delivery system for bone morphogenetic protein.
  11. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
  12. Domb Abraham J. (Baltimore MD), Biodegradable polymer compositions.
  13. Langer Robert S. (Somerville MA) Rosen Howard (Montara CA) Linhardt Robert J. (Iowa City IA) Leong Kam (Cambridge MA), Bioerodible polyanhydrides for controlled drug delivery.
  14. Gerhart Tobin N. (Brockline MA) Laurencin Cato T. (Somerville MA) Domb Abraham J. (Baltimore MD) Langer Robert S. (Newton MA) Hayes Wilson C. (Lincoln MA), Bioerodible polymers for drug delivery in bone.
  15. Kuberasampath Thangavel (Medway MA) Ridge Richard J. (Acton MA), Bone collagen matrix for implants.
  16. Domb Abraham J. (Baltimore MD) Maniar Manoj (Baltimore MD), Branched polyanhydrides.
  17. Domb Abraham J. (Baltimore MD) Maniar Manoj (Baltimore MD), Branched polyanhydrides.
  18. Hutchinson Francis G. (Lymm GBX), Continuous release pharmaceutical compositions.
  19. Langer Robert S. (Sommerville MA) Domb Abraham J. (Brookline MA) Laurencin Cato T. (Cambridge MA), Controlled drug delivery high molecular weight polyanhydrides.
  20. Park Tae G. (Cambridge MA) Cohen Smadar (Petach-Tickva MA ILX) Langer Robert S. (Newton MA), Controlled drug delivery using polymer/pluronic blends.
  21. Morita Yasushi (Osaka JPX) Ohtori Akira (Fukuoka JPX) Andoh Masako (Hyogo JPX), Controlled drug release composition.
  22. Khan M. Amin (Burlington MA) Bernstein Howard (Cambridge MA), Controlled release ACTH containing microspheres.
  23. Schmitt Edward Emil (Palo Alto CA) Polistina Rocco Albert (Port Chester NY), Controlled release of medicaments using polymers from glycolic acid.
  24. Sparks Randall T. (Gainesville GA) Geoghegan Edward J. (Athlone IEX), Controlled release powder and process for its preparation.
  25. Labrie Fernand (Quebec CAX) Lepage Martin (Quebec CAX), Controlled release systems and low dose androgens.
  26. Laurencin Cato T. (Somerville MA) Lucas Paul A. (Macon GA) Syftestad Glenn T. (Sacramento CA) Domb Abraham (Baltimore MD) Glowacki Julianne (Jamaica Plan MA) Langer Robert S. (Newton MA), Delivery system for controlled release of bioactive factors.
  27. Schmitt Edward E. (Palo Alto CA), Drug delivery devices comprising erodible polymer and erosion rate modifier.
  28. Choi ; Nam Sok ; Heller ; Jorge, Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates).
  29. Higuchi ; Takeru ; Hussain ; Anwar, Drug-delivery device comprising certain polymeric materials for controlled release of drug.
  30. Capozza Richard C. (Paradise Valley AZ), Erodible device comprising surfactant for modifying the rate of erosion of the device.
  31. Sabel Bernhard A. (Kreuzberg 6 8011 Egmating MA DEX) Freese Andrew (115 Whitcomb Ave. Jamaica Plain MA 02130), Extended drug delivery of small, water-soluble molecules.
  32. Domb Abraham J. (Baltimore MD) Maniar Manoj (Baltimore MD), Fatty acid terminated polyanhydrides.
  33. Domb Abraham J. (Brookline MA) Langer Robert S. (Somerville MA), High molecular weight polyanhydride and preparation thereof.
  34. Casey ; Donald J. ; Gleckler ; George C., High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical compositio.
  35. Yamahira Yoshiya (Kobe JPX) Fujioka Keiji (Amagasaki JPX) Sato Shiegeji (Ibaraki JPX) Takada Yoshihiro (Takatsuki JPX), Long-term sustained-release preparation.
  36. Yamahira Yoshiya (Kobe JPX) Fujioka Keiji (Amagasaki JPX) Sato Shigeji (Ibaraki JPX) Takada Yoshihiro (Takatsuki JPX), Long-term sustained-release preparation.
  37. Anderson Mark E. (21 Southampton Ct. Newport Beach CA 92660), Method for administering interleukin-2.
  38. Onwumere Fidelis C. (Miamisburg OH) Solomon Donald D. (Spring Valley OH) Wells Stanley C. (Dayton OH), Method for rendering a substrate surface antithrombogenic and/or anti-infective.
  39. Heller Jorge (Woodside CA) Penhale Donald W. H. (Menlo Park CA) Ng Steve Y. (San Francisco CA), Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product.
  40. Gold Joseph (127 Edgemont Dr. Syracuse NY 13214), Method of prolonging cancerous patient survival in humans with hydrazine sulfate.
  41. Brown Dennis M. (Menlo Park CA) Jones Richard E. (Palo Alto CA) Maskiewicz Richard (Sunnyvale CA) Michaels Shawnya K. (Pacifica CA), Methods and compositions for the treatment of a host with a cellular proliferative disease.
  42. Desai Neil P. (Los Angeles CA) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Grinstaff Mark W. (Pasadena CA) Suslick Kenneth S. (Champaign IL), Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful th.
  43. Sadek Safik E. (Wayland MA), Methods of improving control of release rates and products useful in same.
  44. Giovannella Beppino C. (Houston TX) Liu Leroy F. (Lutherville MD) Potmesil Milan (New York NY) Wall Monroe C. (Chapel Hill NC) Silber Robert F. (New York NY) Wani Mansukh C. (Durham NC), Methods of treating colon tumors with tumor-inhibiting camptothecin compounds.
  45. Bontemps Jos (Xhendremael BEX) Pirson Philippe (Wezembeek-Oppem BEX) Falmagne Jean-Bernard (Wavre BEX) Jerome Robert (Tilff BEX) Teyssie Philippe (Condroz BEX) Delattre Luc (Oupeye BEX) Evrard Brigit, Microparticles comprising a biodegradable polymer controlling the release of an antimalaria active principle, pharmaceut.
  46. Deasy Patrick B. (Dublin IEX), Multi-component long-acting medicament formulation for implantation.
  47. Zaffaroni Alejandro (Atherton CA), Novel drug delivery device.
  48. Lee Yue-Wei (Research Triangle Park NC) Fang Qi-Cheng (Beijing TWX) Wang Zhen-Guo (Jilin TWX) Li De-Hua (Jilin NC TWX) Cook C. E. (Research Trinagle Park NC), Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers.
  49. Orsolini Piero (Martigny CHX), Pharmaceutical composition in the form of microparticles.
  50. Hubbell Jeffrey A. (Austin TX) Pathak Chandrashekhar P. (Waltham MA) Sawhney Amarpreet S. (Newton MA) Desai Neil P. (Los Angeles CA) Hill Jennifer L. (Austin TX), Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers.
  51. Ron Eyal (Lexington MA) Chasin Mark (Englishtown NJ) Turek Tom (Dorchester MA) Langer Robert S. (Newton MA), Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone.
  52. Domb Abraham J. (Baltimore MD), Polyanhydrides of oligomerized unsaturated aliphatic acids.
  53. Domb Abraham J. (Brookline MA) Langer Robert S. (Somerville MA), Polyanhydrides with improved hydrolytic degradation properties.
  54. Speiser Peter (Zurich CHX) Schleuniger Urs (Zurich CHX) Orsolini Piero (Martigny CHX) Heimgartner Frdric (Martigny CHX), Polyester-based composition for the controlled release of polypeptide medicinal substances.
  55. Hyon Suong-Hyu (Uji JPX) Ikada Yoshita (Uji JPX), Polylactic acid type microspheres containing physiologically active substance and process for preparing the same.
  56. Yamamoto Masaki (Osaka JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Miyagawa Tsutomu (Saitama JPX), Polymer, production and use thereof.
  57. Amsden Brian G. (40 Fountainhead Rd. ; Apt. #1516 Downsview ; Ontario M3J 2V1 CAX) Cheng Yu-Ling (1399 Glenburnie Rd. Mississauga Ontario L5G 3C7 CAX), Polymer-based drug delivery system.
  58. Mongelli Nicola (Milan ITX) Angelucci Francesco (Milan ITX) Pesenti Enrico (Cologno Monzese ITX) Suarato Antonino (Milan ITX) Biasoli Giovanni (Gavirate ITX), Polymer-bound paclitaxel derivatives.
  59. McGinity James W. (Austin TX) Iwata Motokazu (Osaka JPX), Preparation and uses of multi-phase microspheres.
  60. Domb Abraham J. (Brookline MA) Langer Robert S. (Somerville MA), Preparation of anhydride copolymers.
  61. Korsatko-Wabnegg Brigitta (Graz ATX) Korsatko Werner (Graz ATX), Pressing having sustained release of active compound.
  62. Brine Charles J. (Princeton NJ), Process for polymerizing poly(lactic acid).
  63. Sparer Randall V. (Lawrence KS) Zentner Gaylen (Lawrence KS), Process for the manufacture of bioerodible poly (orthoester)s and polyacetals.
  64. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Prolonged release microcapsule of a water-soluble drug.
  65. Yamada Minoru (Kawanishi JPX) Ishiguro Seiko (Kawanishi JPX) Ogawa Yasuaki (Otokuni JPX), Prolonged release preparation and polymers thereof.
  66. Martin Francis J. (San Francisco CA) Woodle Martin C. (Menlo Park CA) Redemann Carl (Walnut Creek CA) Yau-Young Annie (Palo Alto CA), Solid tumor treatment method and composition.
  67. Liversidge Gary G. (West Chester PA) Cundy Kenneth C. (Pottstown PA) Bishop John F. (Rochester NY) Czekai David A. (Honeoye Falls NY), Surface modified drug nanoparticles.
  68. Yamahira Yoshiya (Kobe JPX) Fujioka Keiji (Amagasaki JPX) Sato Shigeji (Ibaraki JPX) Takada Yoshihiro (Takatsuki JPX), Sustained-release injection.
  69. Friedman Michael (Jerusalem ILX) Steinberg Doron (Jerusalem ILX) Soskolne Aubrey (Jerusalem ILX), Sustained-release pharmaceutical compositions.
  70. Brown Dennis M. (Menlo Park CA) Luck Edward (Menlo Park CA) Twardzik Daniel R. (Bainbridge Island WA) Purchio Anthony F. (Seattle WA), TGF-b 상세보기
  • Luck Edward E. (Menlo Park CA) Brown Dennis M. (Menlo Park CA), Treatments employing drug-containing matrices for introduction into cellular lesion areas.
  • Luck Edward E. (Menlo Park CA) Brown Dennis M. (Menlo Park CA), Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular les.
  • Vishnuvajjala B. Rao (Rockville MD) Garzon-Aburbeh Aaron (St. Louis Park MN), Water soluble prodrugs of camptothecin.
  • Bae You H. (Salt Lake City UT), pH and temperature sensitive terpolymers for oral drug delivery.
  • 이 특허를 인용한 특허 (22)

    1. Bankiewicz, Krystof S., Administration of growth factors for the treatment of CNS disorders.
    2. Bankiewicz, Krystof S., Administration of growth factors for the treatment of CNS disorders.
    3. Bankiewicz, Krystof S., Administration of growth factors for the treatment of CNS disorders.
    4. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
    5. Shih, Chung; Zentner, Gaylen M., Biodegradable block copolymeric compositions for drug delivery.
    6. Shih, Chung; Zentner, Gaylen M., Biodegradable block copolymeric compositions for drug delivery.
    7. Shih, Chung; Zentner, Gaylen M., Biodegradable block copolymeric compositions for drug delivery.
    8. Hunter, William L.; Gravett, David M.; Toleikis, Philip M.; Liggins, Richard T.; Loss, Troy A. E., Compositions and methods for coating medical implants.
    9. Roorda, Wouter E.; Pacetti, Stephen D., Compositions for achieving a therapeutic effect in an anatomical structure.
    10. Roorda, Wouter E.; Pacetti, Stephen D., Compositions for achieving a therapeutic effect in an anatomical structure.
    11. Roorda, Wouter E.; Pacetti, Stephen D., Compositions for achieving a therapeutic effect in an anatomical structure.
    12. Roorda, Wouter E.; Pacetti, Stephen D., Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same.
    13. Grahn, Amy; Luz, Matthias, Convection-enhanced delivery catheter with removable stiffening member and method for using same.
    14. Piferi, Peter, Intrabody fluid transfer devices, systems and methods.
    15. Piferi, Peter; Jenkins, Kimble, MRI surgical systems including MRI-compatible surgical cannulae for transferring a substance to and/or from a patient.
    16. Staas, Jay K.; Tice, Thomas R.; Hudson, Bruce W.; Tipton, Arthur J., Methods for manufacturing delivery devices and devices thereof.
    17. Biggs, Danielle; Nettles, Heather, Process for preparing microparticles having a low residual solvent volume.
    18. Bankiewicz, Krystof S., Reflux resistant cannula and system for chronic delivery of therapeutic agents using convection-enhanced delivery.
    19. Rodriguez Ponce, Maria Inmaculada; Pedain, Christoph; Hartlep, Andreas, Risk assessment for planned trajectories.
    20. Bankiewicz, Krystof; Sommer, Jurg M., Stepped cannula.
    21. Bankiewicz, Krzysztof; Sommer, Jürg M., Stepped cannula.
    22. Bankiewicz, Krzysztof; Sommer, Jürg M., Stepped cannula.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로